Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 111

Sort by

Sort Order Select

Journal Articles

History of Autoimmune Disease Is Associated with Increased Risk for Myelodysplastic Syndromes

Michelle A. Roesler, BS, Amy Linabery, PhD MS, Michaela Richardson, MPH, Adina Cioc, MD, Betsy A Hirsch, PhD, Phuong L. Nguyen, MD, Erica D. Warlick, MD, Jenny Poynter, PhD

Blood (2019) 134 (Supplement_1): 3014.

https://doi.org/10.1182/blood-2019-130940

Published: 2019

Journal Articles

Therapy Related Myeloid Neoplasms- Clinical, Pathologic and Genetic Characteristics - a Single Center Experience

Dina Sameh Soliman, MD MB, MMSc, Ahmed Al-Sabbagh, MD, Shehab Fareed Mohamed, MD, Susanna Jane Akiki, PhD, Halima El-Omri, MD, Firyal Ibrahim, MD, Mohamed A Yassin, MBBS, MSc, Prem Chandra, PhD

Blood (2019) 134 (Supplement_1): 5169.

https://doi.org/10.1182/blood-2019-124951

Published: 2019

Journal Articles

Selinexor in Combination with Induction and Consolidation Therapy in Older Adults with AML Is Highly Active

Timothy S. Pardee, MD PhD, Kris C Wood, PhD, Kevin H Lin, BS, Justine Rutter, PhD, Mariaelena Pierobon, MD, Emanuel Petricoin, PhD, Susan Lyerly, P.A.-C., Sarah Dralle, NP, Megan Manuel, NP, Leslie Renee Ellis, MD, Dianna S. Howard, MD, Rupali Bhave, MD, Bayard L Powell, MD

Blood (2019) 134 (Supplement_1): 1388.

https://doi.org/10.1182/blood-2019-129413

Published: 2019

Journal Articles

Imidazoacridinone C-1311 Triggers a Switch from Autophagy to Apoptosis By Blocking FLT3-Dependent ATF4 Transcription Factor in FLT3-ITD Acute Myeloid Leukemia

Anna Skwarska, PhD, Natalia Baran, PhD MD, Marina Y. Konopleva, MD PhD

Blood (2018) 132 (Supplement 1): 3940.

https://doi.org/10.1182/blood-2018-99-114846

Published: 2018

Journal Articles

Therapy-Related Myeloid Neoplasms with Balanced Chromosome Rearrangements Frequently Arise from Pre-Existing Clonal Haematopoiesis

Richard Dillon, MA, PhD MRCP, FRCPath, Jelena Jovanovic, PhD, Nicola Potter, PhD, Nicola Foot, MSc, Matthew J Ahearne, MD MBBS, Sandrine Jayne, PhD, Michael Dennis, MD MRCP, FRCPath, Ann E. Hunter, MBBS, FRCP, FRCPath, Martin J.S. Dyer, Paresh Vyas, Lynn Quek, FRCPath, DPhil, MBBS, Nigel H. Russell, Robert K. Hills, MA, DPhil, MSc, Ellen Solomon, PhD, David Grimwade, PhD MRCP, MRCPath

Blood (2018) 132 (Supplement 1): 2570.

https://doi.org/10.1182/blood-2018-99-114233

Published: 2018

Journal Articles

Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/RarÎ± Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: In Vitro and In Vivo studies

Dijiong Wu, Keding Shao, MD, Qihao Zhou, MD, Jie Sun, Ziqi Wang, Fei Yan, Tingting Liu, Xiangping Wu, Baodong Ye, He Huang, MD PhD, Yuhong Zhou

Blood (2018) 132 (Supplement 1): 2646.

https://doi.org/10.1182/blood-2018-99-115699

Published: 2018

Journal Articles

Impact of Bioflavonoid Exposure on DNA Damage Response and of Non-Homologous End Joining (NHEJ) Pathway Repair Proteins in Stem Cells

Anindita Ghosh, MBBS, MSc, Christine Richardson, PhD

Blood (2017) 130 (Supplement 1): 3796.

https://doi.org/10.1182/blood.V130.Suppl_1.3796.3796

Published: 2017

Journal Articles

Integration of Functional Ex Vivo Drug Testing and Molecular Profiling Reveals Novel Vulnerabilities in CMML

Tea Pemovska, PhD, Gregory Ian Vladimer, PhD, Vitaly Sedlyarov, PhD, Emir Hadzijusufovic, DVM, Karoline Veronika Gleixner, MD, Alexandra Keller, MSc, Berend Snijder, PhD, Nikolaus Krall, PhD, Oscar Lopez de la Fuente, BSc, Mathias A Schneeweiss, MD, Wolfgang R. Sperr, MD, Paul Knöbl, MD PhD, Klaus Geissler, MD, Philipp Bernhard Staber, MD PhD, Ulrich Jaeger, MD, Peter Valent, MD, Giulio Superti Furga, PhD

Blood (2017) 130 (Supplement 1): 4227.

https://doi.org/10.1182/blood.V130.Suppl_1.4227.4227

Published: 2017

Journal Articles

Chemotherapy and Radiation Results in Distinct Patterns of Somatic Mutations in Subsequent Myeloid Disease

Teodora Kuzmanovic, BA, Tomas Radivoyevitch, PhD, Srinivasa Reddy Sanikommu, MD, Bhumika J. Patel, MD, Yasunobu Nagata, MD PhD, Cassandra M. Hirsch, BS, Bartlomiej P. Przychodzen, MSc, Sudipto Mukherjee, MD PhD MPH, Anjali S. Advani, MD, Aziz Nazha, MD, Aaron T. Gerds, MDMS, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, PhD MD FACP

Blood (2017) 130 (Supplement 1): 1673.

https://doi.org/10.1182/blood.V130.Suppl_1.1673.1673

Published: 2017

Journal Articles

Enhance the Efficacy of Doxorubicin Destabilizing the G2/M Checkpoint with a CHK1/CHK2 Inhibitor Pre-Treatment on Acute Lymphoblastic Leukemia

Andrea Ghelli Luserna di Rora', Anna Ferrari, PhD, Enrica Imbrogno, Valentina Robustelli, Cristina Papayannidis, MD, maria Chiara Abbenante, Giovanni Marconi, MD, Michele Cavo, MD, Giovanni Martinelli, MD

Blood (2017) 130 (Supplement 1): 5049.

https://doi.org/10.1182/blood.V130.Suppl_1.5049.5049

Published: 2017

Journal Articles

Tumor Associated Macrophages and Topoisomerase II Alpha As Prognostic Factors in Advanced Stage Hodgkin's Lymphoma

Thoraya Abdel Hamid, MD, Fouad Abu Taleb, MD, Adel Bakry, Master Degree, Asmaa Salama, MD, Ayman Gaber, MD, Shereen El Shorbagy, MD, Mona Ramadan, MD, Nelly Ali El Din, MD

Blood (2017) 130 (Supplement 1): 5183.

https://doi.org/10.1182/blood.V130.Suppl_1.5183.5183

Published: 2017

Journal Articles

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML

Blood (2017) 130 (6): 789–802.

https://doi.org/10.1182/blood-2016-02-699363

Published: 2017

Includes: Supplemental data

Journal Articles

The Bone Marrow Environment Promotes Resistance to Mitoxantrone and Etoposide By Distinct Mechanisms in Pediatric AML

Xin Long, PhD, Michele S. Redell, MD PhD

Blood (2016) 128 (22): 3943.

https://doi.org/10.1182/blood.V128.22.3943.3943

Published: 2016

Journal Articles

Mechanisms of Resistance to Apto-253

Cheng-Yu Tsai, PhD, Hongying Zhang, MD PhD, Andrea Local, PhD, William G. Rice, PhD, Stephen B Howell, MD

Blood (2016) 128 (22): 5247.

https://doi.org/10.1182/blood.V128.22.5247.5247

Published: 2016

Journal Articles

Displacement of Coilin in Cajal Body Is Related to Drug Resistance of Childhood Acute Lymphoblastic Leukemia

Zhixia Yue, Yaoyao Song, Jing Niu, Shuguang Liu, PhD, Wei Ding

Blood (2016) 128 (22): 5143.

https://doi.org/10.1182/blood.V128.22.5143.5143

Published: 2016

Journal Articles

A Phase I Study of Vosaroxin Plus Azacitidine for Patients with Myelodysplastic Syndrome

Meagan A. Jacoby, MD PhD, Camille N. Abboud, MD FACP, John F Dipersio, MD PhD, Amanda F. Cashen, MD, Matthew J. Walter, MD, Rigoberto De Jesus Pizarro, Geoffrey L. Uy, MD

Blood (2015) 126 (23): 1686.

https://doi.org/10.1182/blood.V126.23.1686.1686

Published: 2015

Journal Articles

Histone Deacetylation Inhibitor Sensitizes T-ALLs to Topoisomerase II Inhibitor By Attenuating G2 Cell Cycle Arrest and Blocking Nuclear Entry of Ctip during DNA Repair

Jin-Hwang Liu, MD PhD, Yu-Hern Lin, MS, Hon-Wen Liu, PhD, Jyh-Pyng Gau, MD

Blood (2015) 126 (23): 4862.

https://doi.org/10.1182/blood.V126.23.4862.4862

Published: 2015

Journal Articles

Association of Setmar Expression with Clinical Characteristics in Chronic Lymphocytic Leukemia

Flavia Z Piazera, MD, Doralina Amaral Rabello, Felipe Araújo Saldanha, Fábio Pitella Silva, Fábio Morato Oliveira, Antonio R. Lucena-Araujo, Eduardo Magalhães Rego, MD, PhD

Blood (2015) 126 (23): 4815.

https://doi.org/10.1182/blood.V126.23.4815.4815

Published: 2015

Journal Articles

Phase I/II Study of Vosaroxin and Decitabine in Newly Diagnosed Older Patients (pts) with Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)

Naval Daver, MD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Elias Jabbour, Naveen Pemmaraju, MD, Kenneth Vaughan, Sherry Pierce, BSN, BA, Marina Konopleva, MD PhD, Tapan Kadia, MD, Courtney DiNardo, MD, Gautam Borthakur, MD, Jorge E. Cortes, MD, Adam R Craig, MD PhD, Farhad Ravandi, MD

Blood (2015) 126 (23): 461.

https://doi.org/10.1182/blood.V126.23.461.461

Published: 2015

Journal Articles

Are Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) Occurring during the Course of Lymphoma (Ly) Always Therapy Related?

Camille Bigenwald, Stephanie Harel, Florian Chevillon, Damien Roos-Weil, Olivier A. Bernard, PhD, Sandy Amorim, MD, Pauline Brice, MD, Ades Lionel, Anne Marie Nloga, Marie Sébert, MD, Thorsten Braun, MD PhD, Virginie Eclache, Catherine Thieblemont, MDPhD, Pierre Fenaux, MD PhD

Blood (2015) 126 (23): 2886.

https://doi.org/10.1182/blood.V126.23.2886.2886

Published: 2015

NARROW

History of Autoimmune Disease Is Associated with Increased Risk for Myelodysplastic Syndromes

Therapy Related Myeloid Neoplasms- Clinical, Pathologic and Genetic Characteristics - a Single Center Experience

Selinexor in Combination with Induction and Consolidation Therapy in Older Adults with AML Is Highly Active

Imidazoacridinone C-1311 Triggers a Switch from Autophagy to Apoptosis By Blocking FLT3-Dependent ATF4 Transcription Factor in FLT3-ITD Acute Myeloid Leukemia

Therapy-Related Myeloid Neoplasms with Balanced Chromosome Rearrangements Frequently Arise from Pre-Existing Clonal Haematopoiesis

Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/RarÎ± Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: In Vitro and In Vivo studies

Impact of Bioflavonoid Exposure on DNA Damage Response and of Non-Homologous End Joining (NHEJ) Pathway Repair Proteins in Stem Cells

Integration of Functional Ex Vivo Drug Testing and Molecular Profiling Reveals Novel Vulnerabilities in CMML

Chemotherapy and Radiation Results in Distinct Patterns of Somatic Mutations in Subsequent Myeloid Disease

Enhance the Efficacy of Doxorubicin Destabilizing the G2/M Checkpoint with a CHK1/CHK2 Inhibitor Pre-Treatment on Acute Lymphoblastic Leukemia

Tumor Associated Macrophages and Topoisomerase II Alpha As Prognostic Factors in Advanced Stage Hodgkin's Lymphoma

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML

The Bone Marrow Environment Promotes Resistance to Mitoxantrone and Etoposide By Distinct Mechanisms in Pediatric AML

Mechanisms of Resistance to Apto-253

Displacement of Coilin in Cajal Body Is Related to Drug Resistance of Childhood Acute Lymphoblastic Leukemia

A Phase I Study of Vosaroxin Plus Azacitidine for Patients with Myelodysplastic Syndrome

Histone Deacetylation Inhibitor Sensitizes T-ALLs to Topoisomerase II Inhibitor By Attenuating G2 Cell Cycle Arrest and Blocking Nuclear Entry of Ctip during DNA Repair

Association of Setmar Expression with Clinical Characteristics in Chronic Lymphocytic Leukemia

Phase I/II Study of Vosaroxin and Decitabine in Newly Diagnosed Older Patients (pts) with Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)

Are Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) Occurring during the Course of Lymphoma (Ly) Always Therapy Related?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only